Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Coagulation function and mechanisms in various clinical phenotypes of patients with acquired factor V inhibitors.

Journal of thrombosis and haemostasis : JTH - 1 Sept 2014

Matsumoto T, Nogami K, Shima M

Abstract excerpt

BACKGROUND: The clinical phenotype of individuals with acquired factor V (A-FV) inhibitors varies from asymptomatic (non-B group) to life-threatening bleeding (B group), but the mechanism(s) underlying this variation in hemorrhagic phenotype are poorly understood. OBJECTIVE: To investigate coagulation mechanistically in a range of patients with A-FV antibodies. METHODS AND RESULTS: Ten cases of A-FV inhibitors in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation Tests
Share to Coagulants
Share to Hemorrhage

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hemostasis

Share to Partial Thromboplastin Time

Share to Protein C

Share to Prothrombin Time

Share to Thromboplastin

Source

Identifiers

PMID: 25041532
DOI: 10.1111/jth.12660

Genes

APC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Coagulation function and mechanisms in various clinical phenotypes of patients with acquired factor V inhibitors.PMID 25041532Read ↗

Functional roles of the factor VIII B domainSemantic proximity Read ↗

Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome.Semantic proximity Read ↗

Factor VIII inhibitors.Semantic proximity Read ↗

Predictive significance of anti-FVIII immunoglobulin patterns on bleeding phenotype and outcomes in acquired hemophilia A: Results from the Quebec Reference Center for Inhibitors.Semantic proximity Read ↗

Anti-C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model.Semantic proximity Read ↗

Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIIISemantic proximity Read ↗

Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.Semantic proximity Read ↗

Characteristics of inhibitors in mild/moderate haemophilia A.Semantic proximity Read ↗

Activated factor X cleaves factor VIII at arginine 562, limiting its cofactor efficiency.Semantic proximity Read ↗

Fine mapping of inhibitory anti-factor V antibodies using factor V C2 domain mutants. Identification of two antigenic epitopes involved in phospholipid binding.Semantic proximity Read ↗

Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy.Semantic proximity Read ↗

Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.